首页> 美国卫生研究院文献>Scientific Reports >Crystal structure of the membrane attack complex assembly inhibitor BGA71 from the Lyme disease agent Borrelia bavariensis
【2h】

Crystal structure of the membrane attack complex assembly inhibitor BGA71 from the Lyme disease agent Borrelia bavariensis

机译:莱姆病病原体Borrelia bavariensis的膜攻击复合物装配抑制剂BGA71的晶体结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Borrelia (B.) bavariensis, B. burgdorferi, B. afzelii, B. garinii, B. spielmanii, and B. mayonii are the causative agents in Lyme disease. Lyme disease spirochetes reside in infected Ixodes ticks and are transferred to mammalian hosts during tick feeding. Once transmitted, spirochetes must overcome the first line of defense of the innate immune system either by binding complement regulators or by terminating the formation of the membrane attack complex (MAC). In B. bavariensis, the proteins BGA66 and BGA71 inhibit complement activation by interacting with the late complement components C7, C8, and C9, as well as with the formed MAC. In this study, we have determined the crystal structure of the potent MAC inhibitor BGA71 at 2.9 Ǻ resolution. The structure revealed a cysteine cross-linked homodimer. Based on the crystal structure of BGA71 and the structure-based sequence alignment with CspA from B. burgdorferi, we have proposed a potential binding site for C7 and C9, both of which are constituents of the formed MAC. Our results shed light on the molecular mechanism of immune evasion developed by the human pathogenic Borrelia species to overcome innate immunity. These results will aid in the understanding of Lyme disease pathogenesis and pave the way for the development of new strategies to prevent Lyme disease.
机译:鲍氏疏螺旋体(B.)bavariensis,B。burgdorferi,B。afzelii,B。garinii,B。spielmanii和B. mayonii是莱姆病的病原体。莱姆病螺旋体生活在受感染的x虱中,在tick喂养期间被转移到哺乳动物宿主中。螺旋体一旦被传播,必须通过结合补体调节剂或终止膜攻击复合物(MAC)的形成来克服先天免疫系统的第一道防线。在巴伐利亚杆菌中,蛋白质BGA66和BGA71通过与晚期补体成分C7,C8和C9以及形成的MAC相互作用而抑制补体激活。在这项研究中,我们确定了有效MAC抑制剂BGA71的晶体结构,分辨率为2.9Ǻ。该结构显示出半胱氨酸交联的同二聚体。基于BGA71的晶体结构和与B. burgdorferi的CspA的基于结构的序列比对,我们提出了C7和C9的潜在结合位点,这两个都是形成的MAC的组成部分。我们的研究结果揭示了人类病原性疏螺旋体为克服先天免疫而开发的逃避免疫的分子机制。这些结果将有助于了解莱姆病的发病机理,并为开发预防莱姆病的新策略铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号